We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Antisoma | ASM | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.325 | 00:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.325 | 1.325 |
| Top Posts |
|---|
Posted at 23/11/2011 11:38 by the_doctor Sadly, this company just strikes me as pointless nowThe products they sold generated barely anything and it sounds as if there'll be no value remaining from those but royalties - which would be years away They should IMO close up and return cash to investors I'm not a shareholder here. The only people that'll make money will be the advisers that take their annual fees. |
Posted at 20/5/2011 09:44 by cumnor Feel the company has done well in managing wind-down, bearing in mind the sensitivities of staff who have worked for years for asm. Remember this company up to three months ago had many well paid well qualified full time scientists/managers etc working so of course it is appropriate that all RNSs stick to the point re current proceedings without emphasing the point that the company has cash, new investors and a strategy in place to reward shareholders while at the same time giving out P60s. Now they have done the necessary i suspect the next RNs's will be focused more clearly on strategy to interest shareholders with probable news on mergers/ acquisitions or even buyout. Ora I suspect already know exactly what is going to happen. imo |
Posted at 20/5/2011 09:04 by cumnor 6 weeks. Still has ip and opportunities, particularly small mining/oil companies, have been devestated over the past three months giving ASM the chance to acquire assets much cheaper than before, even when they had more cash. This is what recovery plays are all about and positioning yourself for the next move. This is where the value of a listing comes into play and with a few heavyweight investors on board not just sitting to take pensions and with shareholders to ansewr to there should be some action soon. But clearly it would be nice to see them moving soon and the listing will facilitate this imo. Considering the size of the company cash burn way less than expected imo. |
Posted at 28/4/2011 08:10 by cumnor Good news I feel. Suggests intention to remain listed but with completely different focus, possibly having taken on some private co like o/g or minerals explo and with significant cash reserves and backing of respected aggresive equity partners this could be due rerating thereafter. Also possibility of decent royalty returns (that is all it could ever have expected and not much less than normL) on it's total antibody ip which will cost nothing and be developed by larger pharma with clout to get anything out of it if it is going to succeed. I am happy to see it with smaller sale price but potential for decent returns long term if it's drugs turn up trumps as keeps investors interested and adds value at each stage if it passes trials. All speculation but i don't think ORA will be happy with anything less than 30p exit at some stage. Cash reserves important but backing of respected large investors and listing could take this anywhere. Certainly things happening as we hoped. Could we see renewed asm with much higher share price in a year or two. I think so. aimo dyor |
Posted at 15/2/2011 15:34 by the_doctor surebut would that generate value? given ASM's track record IMO if they acquired something, most investors wouldnt want to price in the cash or the IP |
Posted at 11/2/2011 09:11 by clubman I do not understand why any personal investor would throw their money down this hole.Better buying Lotto tickets with you money, you would have more chance of a profit. |
Posted at 08/2/2011 15:45 by trackerjack Hi thereThis has just appeared on the Growth Company Investor site |
Posted at 02/2/2011 13:45 by the_doctor2 Ora will possibly use it to float something into IMO. That makes the most sense.Will it give any return for investors here? Not much, if any IMO. |
Posted at 31/1/2011 09:24 by gdasinv2 For New investor - it is new begning , having cash in hand 23Million more than current mkt cap and current lern from the trialing ....it is new begnning , also see short term 4-5p at least. For me not a problem. Also ISABLE. |
Posted at 15/11/2010 17:09 by leedskier Yes Topicel, moths have a longer life span than many investors hold a share, i.e. a week or two. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
